v3.8.0.1

Valuation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2017
Fair Value Disclosures [Abstract] |
Schedule Of Financial Instruments | The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at September 30, 2017:
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  | (In thousands)
Cash equivalents |  | $ | 60,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 60,000 |
Investments, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | 931,391 |  |  | $ | 5,819 |  |  | $ | 937,210 |
U.S. Treasury securities |  | — |  |  | 1,519 |  |  | — |  |  | 1,519 |
Private label residential mortgage-backed securities |  | — |  |  | 78,553 |  |  | 73,648 |  |  | 152,201 |
Private label commercial mortgage-backed securities |  | — |  |  | 18,421 |  |  | 11,632 |  |  | 30,053 |
Commercial mortgage loans |  | — |  |  | — |  |  | 67,895 |  |  | 67,895 |
Residential mortgage loans |  | — |  |  | — |  |  | 162,963 |  |  | 162,963 |
Collateralized loan obligations |  | — |  |  | 108,146 |  |  | 26,918 |  |  | 135,064 |
Consumer loans and asset-backed securities backed by consumer loans |  | — |  |  | — |  |  | 116,340 |  |  | 116,340 |
Corporate debt |  | — |  |  | 76,400 |  |  | 12,908 |  |  | 89,308 |
Real estate owned |  | — |  |  | — |  |  | 25,762 |  |  | 25,762 |
Corporate equity investments |  | 790 |  |  | — |  |  | 37,327 |  |  | 38,117 |
Total investments, at fair value |  | 790 |  |  | 1,214,430 |  |  | 541,212 |  |  | 1,756,432 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities |  | — |  |  | — |  |  | 4,530 |  |  | 4,530 |
Credit default swaps on corporate bond indices |  | — |  |  | 631 |  |  | — |  |  | 631 |
Credit default swaps on corporate bonds |  | — |  |  | 10,109 |  |  | — |  |  | 10,109 |
Credit default swaps on asset-backed indices |  | — |  |  | 6,987 |  |  | — |  |  | 6,987 |
Interest rate swaps |  | — |  |  | 6,721 |  |  | — |  |  | 6,721 |
Options |  | 50 |  |  | 2 |  |  | — |  |  | 52 |
Futures |  | 143 |  |  | — |  |  | — |  |  | 143 |
Forwards |  | — |  |  | 723 |  |  | — |  |  | 723 |
Total financial derivatives–assets, at fair value |  | 193 |  |  | 25,173 |  |  | 4,530 |  |  | 29,896 |
Repurchase agreements |  | — |  |  | 193,070 |  |  | — |  |  | 193,070 |
Total investments and financial derivatives–assets, at fair value and repurchase agreements |  | $ | 983 |  |  | $ | 1,432,673 |  |  | $ | 545,742 |  |  | $ | 1,979,398 |
Liabilities: |  |  |  |  |  |  |  |
Investments sold short, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | (470,487 | ) |  | $ | — |  |  | $ | (470,487 | )
Government debt |  | — |  |  | (120,407 | ) |  | — |  |  | (120,407 | )
Corporate debt |  | — |  |  | (70,567 | ) |  | — |  |  | (70,567 | )
Common stock |  | (14,189 | ) |  | — |  |  | — |  |  | (14,189 | )
Total investments sold short, at fair value |  | (14,189 | ) |  | (661,461 | ) |  | — |  |  | (675,650 | )
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
(continued) |  | (In thousands)
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on corporate bond indices |  | $ | — |  |  | $ | (11,646 | ) |  | $ | — |  |  | $ | (11,646 | )
Credit default swaps on corporate bonds |  | — |  |  | (13,611 | ) |  | — |  |  | (13,611 | )
Credit default swaps on asset-backed indices |  | — |  |  | (1,495 | ) |  | — |  |  | (1,495 | )
Credit default swaps on asset-backed securities |  | — |  |  | — |  |  | (207 | ) |  | (207 | )
Interest rate swaps |  | — |  |  | (5,303 | ) |  | — |  |  | (5,303 | )
Forwards |  | — |  |  | (16 | ) |  | — |  |  | (16 | )
Total financial derivatives–liabilities, at fair value |  | — |  |  | (32,071 | ) |  | (207 | ) |  | (32,278 | )
Total investments sold short and financial derivatives–liabilities, at fair value |  | $ | (14,189 | ) |  | $ | (693,532 | ) |  | $ | (207 | ) |  | $ | (707,928 | )
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2016:
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  | (In thousands)
Cash equivalents |  | $ | 90,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 90,000 |
Investments, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | 868,345 |  |  | $ | 29,622 |  |  | $ | 897,967 |
U.S. Treasury securities |  | — |  |  | 5,419 |  |  | — |  |  | 5,419 |
Private label residential mortgage-backed securities |  | — |  |  | 53,525 |  |  | 90,083 |  |  | 143,608 |
Private label commercial mortgage-backed securities |  | — |  |  | — |  |  | 43,268 |  |  | 43,268 |
Commercial mortgage loans |  | — |  |  | — |  |  | 61,129 |  |  | 61,129 |
Residential mortgage loans |  | — |  |  | — |  |  | 84,290 |  |  | 84,290 |
Collateralized loan obligations |  | — |  |  | — |  |  | 44,956 |  |  | 44,956 |
Consumer loans and asset-backed securities backed by consumer loans(1) |  | — |  |  | — |  |  | 107,157 |  |  | 107,157 |
Corporate debt |  | — |  |  | 55,091 |  |  | 25,004 |  |  | 80,095 |
Real estate owned |  | — |  |  | — |  |  | 3,349 |  |  | 3,349 |
Corporate equity investments(1) |  | 4,396 |  |  | — |  |  | 29,392 |  |  | 33,788 |
Total investments, at fair value |  | 4,396 |  |  | 982,380 |  |  | 518,250 |  |  | 1,505,026 |
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
(continued) |  | (In thousands)
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities |  | $ | — |  |  | $ | — |  |  | $ | 5,326 |  |  | $ | 5,326 |
Credit default swaps on corporate bond indices |  | — |  |  | 2,744 |  |  | — |  |  | 2,744 |
Credit default swaps on corporate bonds |  | — |  |  | 2,360 |  |  | — |  |  | 2,360 |
Credit default swaps on asset-backed indices |  | — |  |  | 16,713 |  |  | — |  |  | 16,713 |
Interest rate swaps |  | — |  |  | 8,102 |  |  | — |  |  | 8,102 |
Total return swaps |  | — |  |  | — |  |  | 155 |  |  | 155 |
Options |  | 42 |  |  | 2 |  |  | — |  |  | 44 |
Futures |  | 29 |  |  | — |  |  | — |  |  | 29 |
Forwards |  | — |  |  | 16 |  |  | — |  |  | 16 |
Warrants |  | — |  |  | — |  |  | 106 |  |  | 106 |
Total financial derivatives–assets, at fair value |  | 71 |  |  | 29,937 |  |  | 5,587 |  |  | 35,595 |
Repurchase agreements |  | — |  |  | 184,819 |  |  | — |  |  | 184,819 |
Total investments and financial derivatives–assets, at fair value and repurchase agreements |  | $ | 4,467 |  |  | $ | 1,197,136 |  |  | $ | 523,837 |  |  | $ | 1,725,440 |
Liabilities: |  |  |  |  |  |  |  |
Investments sold short, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | (404,728 | ) |  | $ | — |  |  | $ | (404,728 | )
Government debt |  | — |  |  | (132,442 | ) |  | — |  |  | (132,442 | )
Corporate debt |  | — |  |  | (39,572 | ) |  | — |  |  | (39,572 | )
Common stock |  | (8,154 | ) |  | — |  |  | — |  |  | (8,154 | )
Total investments sold short, at fair value |  | (8,154 | ) |  | (576,742 | ) |  | — |  |  | (584,896 | )
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on corporate bond indices |  | — |  |  | (2,840 | ) |  | — |  |  | (2,840 | )
Credit default swaps on corporate bonds |  | — |  |  | (6,654 | ) |  | — |  |  | (6,654 | )
Credit default swaps on asset-backed indices |  | — |  |  | (2,899 | ) |  | — |  |  | (2,899 | )
Credit default swaps on asset-backed securities |  | — |  |  | — |  |  | (256 | ) |  | (256 | )
Interest rate swaps |  | — |  |  | (5,162 | ) |  | — |  |  | (5,162 | )
Total return swaps |  | — |  |  | (55 | ) |  | (249 | ) |  | (304 | )
Futures |  | (69 | ) |  | — |  |  | — |  |  | (69 | )
Forwards |  | — |  |  | (472 | ) |  | — |  |  | (472 | )
Mortgage loan purchase commitments |  | — |  |  | (31 | ) |  | — |  |  | (31 | )
Total financial derivatives–liabilities, at fair value |  | (69 | ) |  | (18,113 | ) |  | (505 | ) |  | (18,687 | )
Total investments sold short, and financial derivatives–liabilities, at fair value |  | $ | (8,223 | ) |  | $ | (594,855 | ) |  | $ | (505 | ) |  | $ | (603,583 | )
Schedule Of Significant Unobservable Inputs, Qualitative Information | The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2016:
|  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Private label residential mortgage-backed securities |  | $ | 47,024 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | $ | 2.00 |  |  | $ | 101.02 |  |  | $ | 67.51 |
Collateralized loan obligations |  | 37,517 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 9.42 |  |  | 100.25 |  |  | 83.36 |
Corporate debt and non-exchange traded corporate equity |  | 19,017 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 1.88 |  |  | 102.25 |  |  | 87.14 |
Private label commercial mortgage-backed securities |  | 27,283 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 5.17 |  |  | 77.75 |  |  | 40.88 |
Agency interest only residential mortgage-backed securities |  | 23,322 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 2.47 |  |  | 20.17 |  |  | 11.65 |
Total return swaps |  | (94 | ) |  | Market Quotes |  | Non Binding Third-Party Valuation (1) |  | 98.25 |  |  | 99.50 |  |  | 98.77 |
Private label residential mortgage-backed securities |  | 43,059 |  |  | Discounted Cash Flows |  | Yield |  | 0.6 | % |  | 20.5 | % |  | 11.0 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 81.0 | % |  | 10.0 | %
|  |  |  |  |  | Projected Collateral Losses |  | 1.4 | % |  | 51.2 | % |  | 41.4 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 0.4 | % |  | 53.6 | % |  | 41.2 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 90.7 | % |  | 7.4 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Private label commercial mortgage-backed securities |  | 15,985 |  |  | Discounted Cash Flows |  | Yield |  | 8.8 | % |  | 57.0 | % |  | 23.6 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.1 | % |  | 5.3 | % |  | 2.2 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 0.9 | % |  | 20.5 | % |  | 10.7 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 77.8 | % |  | 99.0 | % |  | 87.1 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Corporate debt and warrants |  | 10,080 |  |  | Discounted Cash Flows |  | Yield |  | 19.7 | % |  | 19.7 | % |  | 19.7 | %
Collateralized loan obligations |  | 7,439 |  |  | Discounted Cash Flows |  | Yield |  | 11.2 | % |  | 50.3 | % |  | 20.5 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 11.4 | % |  | 55.2 | % |  | 45.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 4.5 | % |  | 28.3 | % |  | 10.7 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 1.5 | % |  | 27.2 | % |  | 8.6 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 29.8 | % |  | 51.5 | % |  | 35.2 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Consumer loans and asset-backed securities backed by consumer loans(2) |  | 107,157 |  |  | Discounted Cash Flows |  | Yield |  | 9.0 | % |  | 25.0 | % |  | 11.0 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 45.4 | % |  | 25.6 | %
|  |  |  |  |  | Projected Collateral Losses |  | 3.3 | % |  | 97.4 | % |  | 9.4 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 87.7 | % |  | 65.0 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Performing commercial mortgage loans |  | 32,557 |  |  | Discounted Cash Flows |  | Yield |  | 8.0 | % |  | 17.2 | % |  | 11.6 | %
(continued) |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Non-performing commercial mortgage loans and commercial real estate owned |  | $ | 30,222 |  |  | Discounted Cash Flows |  | Yield |  | 10.2 | % |  | 27.8 | % |  | 16.3 | %
|  |  |  |  |  | Months to Resolution |  | 3.0 |  |  | 39.1 |  |  | 19.5 |
Performing residential mortgage loans |  | 78,576 |  |  | Discounted Cash Flows |  | Yield |  | 5.0 | % |  | 13.5 | % |  | 6.6 | %
Non-performing residential mortgage loans and residential real estate owned |  | 7,413 |  |  | Discounted Cash Flows |  | Yield |  | 5.8 | % |  | 39.9 | % |  | 9.7 | %
|  |  |  |  |  | Months to Resolution |  | 1.8 |  |  | 162.9 |  |  | 41.9 |
Credit default swaps on asset-backed securities |  | 5,070 |  |  | Net Discounted Cash Flows |  | Projected Collateral Prepayments |  | 19.3 | % |  | 29.8 | % |  | 22.7 | %
|  |  |  |  |  | Projected Collateral Losses |  | 15.3 | % |  | 27.6 | % |  | 22.2 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 4.7 | % |  | 15.3 | % |  | 8.7 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 43.2 | % |  | 50.2 | % |  | 46.4 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Non-exchange traded equity investments in commercial mortgage-related private partnerships |  | 3,090 |  |  | Discounted Cash Flows |  | Yield |  | 16.5 | % |  | 16.5 | % |  | 16.5 | %
|  |  |  |  |  | Expected Holding Period (Months) |  | 2.9 |  |  | 2.9 |  |  | 2.9 |
Agency interest only residential mortgage-backed securities |  | 6,300 |  |  | Option Adjusted Spread ("OAS") |  | LIBOR OAS(3) |  | 142 |  |  | 2,831 |  |  | 568 |
|  |  |  |  |  | Projected Collateral Prepayments(2) |  | 0.0 | % |  | 100.0 | % |  | 63.6 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 88.1 | % |  | 36.4 | %
|  |  |  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Non-exchange traded preferred and common equity investment in mortgage-related entity |  | 2,500 |  |  | Enterprise Value |  | Equity Price-to-Book(4) |  | 1.3x |  |  | 1.3x |  |  | 1.3x |
Non-controlling equity interest in limited liability company(2) |  | 7,315 |  |  | Net Discounted Cash Flows |  | Yield |  | 8.5 | % |  | 8.5 | % |  | 8.5 | %
Non-exchange traded preferred equity investment in mortgage-related entity |  | 12,500 |  |  | Recent Transactions |  | Transaction Price |  | N/A |  |  | N/A |  |  | N/A |
(1) | Represents valuations on underlying assets.
(2) | Conformed to current period presentation.
(3) | Shown in basis points.
(4) | Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of September 30, 2017:
|  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Private label residential mortgage-backed securities |  | $ | 23,182 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | $ | 46.28 |  |  | $ | 478.10 |  |  | $ | 95.08 |
Collateralized loan obligations |  | 24,586 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 3.10 |  |  | 440.00 |  |  | 122.21 |
Corporate debt and non-exchange traded corporate equity |  | 9,782 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 0.88 |  |  | 99.50 |  |  | 81.87 |
Private label commercial mortgage-backed securities |  | 7,721 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 5.36 |  |  | 42.00 |  |  | 18.18 |
Agency interest only residential mortgage-backed securities |  | 502 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 16.89 |  |  | 18.44 |  |  | 17.85 |
Private label residential mortgage-backed securities |  | 50,466 |  |  | Discounted Cash Flows |  | Yield |  | 1.7 | % |  | 25.6 | % |  | 9.8 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 2.5 | % |  | 84.6 | % |  | 44.0 | %
|  |  |  |  |  | Projected Collateral Losses |  | 1.3 | % |  | 18.2 | % |  | 9.0 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 0.0 | % |  | 13.9 | % |  | 6.4 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 12.9 | % |  | 90.7 | % |  | 40.6 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Private label commercial mortgage-backed securities |  | 3,911 |  |  | Discounted Cash Flows |  | Yield |  | 9.1 | % |  | 50.1 | % |  | 23.1 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.1 | % |  | 5.1 | % |  | 2.2 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 1.3 | % |  | 14.8 | % |  | 8.0 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 80.1 | % |  | 98.6 | % |  | 89.8 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Corporate debt and non-exchange traded corporate equity |  | 7,194 |  |  | Discounted Cash Flows |  | Yield |  | 8.7 | % |  | 16.1 | % |  | 15.0 | %
(continued) |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Collateralized loan obligations |  | $ | 2,332 |  |  | Discounted Cash Flows |  | Yield |  | 11.2 | % |  | 58.7 | % |  | 26.9 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 67.8 | % |  | 68.7 | % |  | 68.4 | %
|  |  |  |  |  | Projected Collateral Losses |  | 18.8 | % |  | 21.0 | % |  | 19.5 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 7.8 | % |  | 12.5 | % |  | 10.9 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | — | % |  | 3.5 | % |  | 1.2 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Consumer loans and asset-backed securities backed by consumer loans |  | 116,340 |  |  | Discounted Cash Flows |  | Yield |  | 9.0 | % |  | 18.4 | % |  | 10.3 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 51.4 | % |  | 36.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.0 | % |  | 95.0 | % |  | 7.2 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 5.0 | % |  | 100.0 | % |  | 56.3 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Performing commercial mortgage loans |  | 61,339 |  |  | Discounted Cash Flows |  | Yield |  | 8.0 | % |  | 15.4 | % |  | 11.1 | %
Non-performing commercial mortgage loans and commercial real estate owned |  | 31,632 |  |  | Discounted Cash Flows |  | Yield |  | 4.5 | % |  | 23.2 | % |  | 12.9 | %
|  |  |  |  |  | Months to Resolution |  | 3.0 |  |  | 12.0 |  |  | 8.7 |
Performing residential mortgage loans |  | 153,709 |  |  | Discounted Cash Flows |  | Yield |  | 1.6 | % |  | 24.7 | % |  | 6.2 | %
Non-performing residential mortgage loans and residential real estate owned |  | 9,940 |  |  | Discounted Cash Flows |  | Yield |  | 0.7 | % |  | 42.9 | % |  | 11.3 | %
|  |  |  |  |  | Months to Resolution(1) |  | 3.0 |  |  | 34.1 |  |  | 12.6 |
Credit default swaps on asset-backed securities |  | 4,323 |  |  | Net Discounted Cash Flows |  | Projected Collateral Prepayments |  | 19.6 | % |  | 26.6 | % |  | 22.7 | %
|  |  |  |  |  | Projected Collateral Losses |  | 14.4 | % |  | 24.6 | % |  | 21.3 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 5.6 | % |  | 15.1 | % |  | 9.5 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 44.2 | % |  | 53.3 | % |  | 46.5 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Agency interest only residential mortgage-backed securities |  | 5,317 |  |  | Option Adjusted Spread ("OAS") |  | LIBOR OAS(2) |  | 423 |  |  | 1,950 |  |  | 729 |
|  |  |  |  |  | Projected Collateral Prepayments |  | 8.7 | % |  | 100.0 | % |  | 71.3 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 91.3 | % |  | 28.7 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Non-exchange traded common equity investment in mortgage-related entity |  | 2,814 |  |  | Enterprise Value |  | Equity Price-to-Book(3) |  | 1.8x |  | 1.8x |  | 1.8x
Non-exchange traded preferred equity investment in mortgage-related entity |  | 19,000 |  |  | Enterprise Value |  | Equity Price-to-Book(3) |  | 1.0x |  | 1.0x |  | 1.0x
Non-controlling equity interest in limited liability company |  | 5,588 |  |  | Market Quotes |  | Non Binding Third-Party Valuation of the Underlying Assets(4) |  | 100.00 |  | 100.00 |  | 100.00
Non-controlling equity interest in limited liability company |  | 5,857 |  |  | Discounted Cash Flows |  | Yield(4) |  | 9.0% |  | 9.0% |  | 9.0%
(1) | Excludes certain loans that are re-performing.
(2) | Shown in basis points.
(3) | Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(4) | Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
Fair Value Measurement Using Significant Unobservable Inputs | The tables below include a roll-forward of the Company's financial instruments for the three and nine month periods ended September 30, 2017 and 2016 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Level 3—Fair Value Measurement Using Significant Unobservable Inputs: Three Month Period Ended September 30, 2017
(In thousands) | Ending Balance as of June 30, 2017 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2017
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 4,896 |  |  | $ | (377 | ) |  | $ | (78 | ) |  | $ | — |  |  | $ | 1,649 |  |  | $ | (28 | ) |  | $ | 772 |  |  | $ | (1,015 | ) |  | $ | 5,819 |
Private label residential mortgage-backed securities | 79,123 |  |  | 261 |  |  | 1,018 |  |  | 409 |  |  | 3,040 |  |  | (9,116 | ) |  | 5,207 |  |  | (6,294 | ) |  | 73,648 |
Private label commercial mortgage-backed securities | 13,809 |  |  | (144 | ) |  | (752 | ) |  | 934 |  |  | 2,100 |  |  | (5,718 | ) |  | 1,713 |  |  | (310 | ) |  | 11,632 |
Commercial mortgage loans | 65,896 |  |  | 140 |  |  | — |  |  | 17 |  |  | 4,342 |  |  | (2,500 | ) |  | — |  |  | — |  |  | 67,895 |
Residential mortgage loans | 136,097 |  |  | (874 | ) |  | 388 |  |  | (1,013 | ) |  | 37,170 |  |  | (8,805 | ) |  | — |  |  | — |  |  | 162,963 |
Collateralized loan obligations | 42,536 |  |  | 346 |  |  | 61 |  |  | (839 | ) |  | 7,108 |  |  | (13,416 | ) |  | — |  |  | (8,878 | ) |  | 26,918 |
Consumer loans and asset-backed securities backed by consumer loans | 108,671 |  |  | (3,366 | ) |  | 500 |  |  | (528 | ) |  | 33,125 |  |  | (22,062 | ) |  | — |  |  | — |  |  | 116,340 |
Corporate debt | 20,535 |  |  | (19 | ) |  | 128 |  |  | (415 | ) |  | 409 |  |  | (7,730 | ) |  | — |  |  | — |  |  | 12,908 |
Real estate owned | 24,977 |  |  | — |  |  | — |  |  | 49 |  |  | 1,137 |  |  | (401 | ) |  | — |  |  | — |  |  | 25,762 |
Corporate equity investments | 35,698 |  |  | — |  |  | 329 |  |  | (806 | ) |  | 4,641 |  |  | (2,535 | ) |  | — |  |  | — |  |  | 37,327 |
Total investments, at fair value | 532,238 |  |  | (4,033 | ) |  | 1,594 |  |  | (2,192 | ) |  | 94,721 |  |  | (72,311 | ) |  | 7,692 |  |  | (16,497 | ) |  | 541,212 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 5,107 |  |  | — |  |  | 603 |  |  | (577 | ) |  | 27 |  |  | (630 | ) |  | — |  |  | — |  |  | 4,530 |
Total return swaps | — |  |  | — |  |  | 21 |  |  | — |  |  | — |  |  | (21 | ) |  | — |  |  | — |  |  | — |
Total financial derivatives– assets, at fair value | 5,107 |  |  | — |  |  | 624 |  |  | (577 | ) |  | 27 |  |  | (651 | ) |  | — |  |  | — |  |  | 4,530 |
Total investments and financial derivatives–assets, at fair value | $ | 537,345 |  |  | $ | (4,033 | ) |  | $ | 2,218 |  |  | $ | (2,769 | ) |  | $ | 94,748 |  |  | $ | (72,962 | ) |  | $ | 7,692 |  |  | $ | (16,497 | ) |  | $ | 545,742 |
(In thousands) | Ending Balance as of June 30, 2017 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2017
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | $ | (207 | ) |  | $ | — |  |  | $ | (20 | ) |  | $ | — |  |  | $ | 20 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (207 | )
Total return swaps | — |  |  | — |  |  | 13 |  |  | — |  |  | (13 | ) |  | — |  |  | — |  |  | — |  |  | — |
Total financial derivatives– liabilities, at fair value | $ | (207 | ) |  | $ | — |  |  | $ | (7 | ) |  | $ | — |  |  | $ | 7 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (207 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the three month period ended September 30, 2017. For Level 3 financial instruments held by the Company at September 30, 2017, change in net unrealized gain (loss) of $(2.9) million and $(0.6) million for the three month period ended September 30, 2017 relate to investments and financial derivatives–assets, respectively. As of June 30, 2017, the Company modified its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedure, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of September 30, 2017, the Company transferred $16.5 million of securities from Level 3 to Level 2 and $7.7 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. Three Month Period Ended September 30, 2016
(In thousands) | Ending Balance as of June 30, 2016 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2016
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 20,506 |  |  | $ | (1,821 | ) |  | $ | (77 | ) |  | $ | (169 | ) |  | $ | 1,385 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 19,824 |
Private label residential mortgage-backed securities | 112,511 |  |  | 256 |  |  | (958 | ) |  | 6,086 |  |  | — |  |  | (23,652 | ) |  | 1,517 |  |  | (13,815 | ) |  | 81,945 |
Private label commercial mortgage-backed securities | 34,942 |  |  | 429 |  |  | 87 |  |  | (292 | ) |  | 5,335 |  |  | (3,556 | ) |  | — |  |  | — |  |  | 36,945 |
Commercial mortgage loans | 49,466 |  |  | 801 |  |  | 72 |  |  | (1,140 | ) |  | 13,226 |  |  | (5,456 | ) |  | — |  |  | — |  |  | 56,969 |
Residential mortgage loans | 46,649 |  |  | 67 |  |  | (78 | ) |  | (66 | ) |  | 24,002 |  |  | (26,499 | ) |  | — |  |  | — |  |  | 44,075 |
Collateralized loan obligations | 33,109 |  |  | (890 | ) |  | (703 | ) |  | 2,844 |  |  | 4,241 |  |  | (10,198 | ) |  | — |  |  | — |  |  | 28,403 |
Consumer loans and asset-backed securities backed by consumer loans | 154,395 |  |  | (2,919 | ) |  | 204 |  |  | (2,290 | ) |  | 51,775 |  |  | (82,066 | ) |  | — |  |  | — |  |  | 119,099 |
Corporate debt | 36,974 |  |  | (52 | ) |  | (1,942 | ) |  | 3,753 |  |  | 83,700 |  |  | (66,116 | ) |  | — |  |  | — |  |  | 56,317 |
Real estate owned | 4,162 |  |  | — |  |  | 53 |  |  | (214 | ) |  | 1,942 |  |  | (2,359 | ) |  | — |  |  | — |  |  | 3,584 |
Private corporate equity investments | 19,418 |  |  | — |  |  | 733 |  |  | 349 |  |  | 5,100 |  |  | (10,082 | ) |  | — |  |  | — |  |  | 15,518 |
Total investments, at fair value | 512,132 |  |  | (4,129 | ) |  | (2,609 | ) |  | 8,861 |  |  | 190,706 |  |  | (229,984 | ) |  | 1,517 |  |  | (13,815 | ) |  | 462,679 |
(In thousands) | Ending Balance as of June 30, 2016 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2016
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | $ | 6,068 |  |  | $ | — |  |  | $ | 604 |  |  | $ | (221 | ) |  | $ | 65 |  |  | $ | (659 | ) |  | $ | — |  |  | $ | — |  |  | $ | 5,857 |
Total return swaps | 824 |  |  | — |  |  | 3,222 |  |  | (628 | ) |  | 954 |  |  | (4,176 | ) |  | — |  |  | — |  |  | 196 |
Warrants | 100 |  |  | — |  |  | — |  |  | — |  |  | 7,486 |  |  | — |  |  | — |  |  | — |  |  | 7,586 |
Total financial derivatives– assets, at fair value | 6,992 |  |  | — |  |  | 3,826 |  |  | (849 | ) |  | 8,505 |  |  | (4,835 | ) |  | — |  |  | — |  |  | 13,639 |
Total investments and financial derivatives–assets, at fair value | $ | 519,124 |  |  | $ | (4,129 | ) |  | $ | 1,217 |  |  | $ | 8,012 |  |  | $ | 199,211 |  |  | $ | (234,819 | ) |  | $ | 1,517 |  |  | $ | (13,815 | ) |  | $ | 476,318 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments sold short, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt | $ | (9,947 | ) |  | $ | — |  |  | $ | (122 | ) |  | $ | (7 | ) |  | $ | 20,974 |  |  | $ | (50,085 | ) |  | $ | — |  |  | $ | — |  |  | $ | (39,187 | )
Total investments sold short, at fair value | (9,947 | ) |  | — |  |  | (122 | ) |  | (7 | ) |  | 20,974 |  |  | (50,085 | ) |  | — |  |  | — |  |  | (39,187 | )
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | (234 | ) |  | — |  |  | 18 |  |  | (67 | ) |  | 47 |  |  | (26 | ) |  | — |  |  | — |  |  | (262 | )
Total return swaps | (1,016 | ) |  | — |  |  | (2,143 | ) |  | (207 | ) |  | 1,890 |  |  | 253 |  |  | — |  |  | — |  |  | (1,223 | )
Total financial derivatives– liabilities, at fair value | (1,250 | ) |  | — |  |  | (2,125 | ) |  | (274 | ) |  | 1,937 |  |  | 227 |  |  | — |  |  | — |  |  | (1,485 | )
Guarantees: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Guarantees | (312 | ) |  | — |  |  | — |  |  | 162 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (150 | )
Total guarantees | (312 | ) |  | — |  |  | — |  |  | 162 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (150 | )
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value | $ | (11,509 | ) |  | $ | — |  |  | $ | (2,247 | ) |  | $ | (119 | ) |  | $ | 22,911 |  |  | $ | (49,858 | ) |  | $ | — |  |  | $ | — |  |  | $ | (40,822 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended September 30, 2016. For Level 3 financial instruments held by the Company at September 30, 2016, change in net unrealized gain (loss) of $0.6 million, $(0.03) million, $0.4 million, $(1.1) million, and $0.2 million, for the three month period ended September 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively. As of September 30, 2016, the Company transferred $13.8 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. In addition, as of September 30, 2016, the Company transferred $1.5 million of non-Agency RMBS from Level 2 to Level 3. Since June 30, 2016, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Nine Month Period Ended September 30, 2017
(In thousands) | Ending Balance as of December 31, 2016 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2017
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 29,622 |  |  | $ | (7,233 | ) |  | $ | (515 | ) |  | $ | (140 | ) |  | $ | 3,962 |  |  | $ | (153 | ) |  | $ | — |  |  | $ | (19,724 | ) |  | $ | 5,819 |
Private label residential mortgage-backed securities | 90,083 |  |  | 1,672 |  |  | 1,334 |  |  | 7,319 |  |  | 31,117 |  |  | (37,278 | ) |  | 15,043 |  |  | (35,642 | ) |  | 73,648 |
Private label commercial mortgage-backed securities | 43,268 |  |  | 574 |  |  | (3,434 | ) |  | 7,873 |  |  | 2,120 |  |  | (31,542 | ) |  | — |  |  | (7,227 | ) |  | 11,632 |
Commercial mortgage loans | 61,129 |  |  | 771 |  |  | 416 |  |  | 1,167 |  |  | 31,887 |  |  | (27,475 | ) |  | — |  |  | — |  |  | 67,895 |
Residential mortgage loans | 84,290 |  |  | (196 | ) |  | 1,469 |  |  | (1,090 | ) |  | 108,356 |  |  | (29,866 | ) |  | — |  |  | — |  |  | 162,963 |
Collateralized loan obligations | 44,956 |  |  | (5,702 | ) |  | 1,477 |  |  | 2,135 |  |  | 52,269 |  |  | (54,305 | ) |  | — |  |  | (13,912 | ) |  | 26,918 |
Consumer loans and asset-backed securities backed by consumer loans(1) | 107,157 |  |  | (9,631 | ) |  | 426 |  |  | (247 | ) |  | 83,138 |  |  | (64,503 | ) |  | — |  |  | — |  |  | 116,340 |
Corporate debt | 25,004 |  |  | 236 |  |  | 676 |  |  | (229 | ) |  | 83,900 |  |  | (96,679 | ) |  | — |  |  | — |  |  | 12,908 |
Real estate owned | 3,349 |  |  | — |  |  | 424 |  |  | (246 | ) |  | 25,348 |  |  | (3,113 | ) |  | — |  |  | — |  |  | 25,762 |
Corporate equity investments(1) | 29,392 |  |  | — |  |  | 1,848 |  |  | (1,529 | ) |  | 16,416 |  |  | (8,800 | ) |  | — |  |  | — |  |  | 37,327 |
Total investments, at fair value | 518,250 |  |  | (19,509 | ) |  | 4,121 |  |  | 15,013 |  |  | 438,513 |  |  | (353,714 | ) |  | 15,043 |  |  | (76,505 | ) |  | 541,212 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 5,326 |  |  | — |  |  | 971 |  |  | (796 | ) |  | 95 |  |  | (1,066 | ) |  | — |  |  | — |  |  | 4,530 |
Total return swaps | 155 |  |  | — |  |  | 243 |  |  | (155 | ) |  | — |  |  | (243 | ) |  | — |  |  | — |  |  | — |
Warrants | 106 |  |  | — |  |  | (100 | ) |  | (6 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total financial derivatives– assets, at fair value | 5,587 |  |  | — |  |  | 1,114 |  |  | (957 | ) |  | 95 |  |  | (1,309 | ) |  | — |  |  | — |  |  | 4,530 |
Total investments and financial derivatives–assets, at fair value | $ | 523,837 |  |  | $ | (19,509 | ) |  | $ | 5,235 |  |  | $ | 14,056 |  |  | $ | 438,608 |  |  | $ | (355,023 | ) |  | $ | 15,043 |  |  | $ | (76,505 | ) |  | $ | 545,742 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | $ | (256 | ) |  | $ | — |  |  | $ | (485 | ) |  | $ | 477 |  |  | $ | 485 |  |  | $ | (428 | ) |  | $ | — |  |  | $ | — |  |  | $ | (207 | )
Total return swaps | (249 | ) |  | — |  |  | (279 | ) |  | 249 |  |  | 291 |  |  | (12 | ) |  | — |  |  | — |  |  | — |
Total financial derivatives– liabilities, at fair value | $ | (505 | ) |  | $ | — |  |  | $ | (764 | ) |  | $ | 726 |  |  | $ | 776 |  |  | $ | (440 | ) |  | $ | — |  |  | $ | — |  |  | $ | (207 | )
(1) | Conformed to current period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the nine month period ended September 30, 2017. For Level 3 financial instruments held by the Company at September 30, 2017, change in net unrealized gain (loss) of $2.8 million, $(0.8) million, and $0.05 million for the nine month period ended September 30, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively. As of June 30, 2017, the Company modified its procedures to determine the level within the hierarchy for certain financial instruments. Under the revised procedure, the Company examines financial instruments individually rather than in cohorts of like instruments as it had previously. As of September 30, 2017, the Company transferred $76.5 million of securities from Level 3 to Level 2 and $15.0 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. Nine Month Period Ended September 30, 2016
(In thousands) | Ending Balance as of December 31, 2015 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2016
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 24,918 |  |  | $ | (5,766 | ) |  | $ | (168 | ) |  | $ | (849 | ) |  | $ | 1,689 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 19,824 |
Private label residential mortgage-backed securities | 116,435 |  |  | 1,518 |  |  | (1,305 | ) |  | 2,995 |  |  | 7,439 |  |  | (34,904 | ) |  | 8,360 |  |  | (18,593 | ) |  | 81,945 |
Private label commercial mortgage-backed securities | 34,145 |  |  | 1,315 |  |  | 409 |  |  | (4,132 | ) |  | 13,179 |  |  | (7,971 | ) |  | — |  |  | — |  |  | 36,945 |
Commercial mortgage loans | 66,399 |  |  | 2,073 |  |  | 254 |  |  | (917 | ) |  | 26,650 |  |  | (37,490 | ) |  | — |  |  | — |  |  | 56,969 |
Residential mortgage loans | 22,089 |  |  | 315 |  |  | 787 |  |  | 61 |  |  | 56,068 |  |  | (35,245 | ) |  | — |  |  | — |  |  | 44,075 |
Collateralized loan obligations | 45,974 |  |  | (3,759 | ) |  | 98 |  |  | 3,261 |  |  | 5,418 |  |  | (22,589 | ) |  | — |  |  | — |  |  | 28,403 |
Consumer loans and asset-backed securities backed by consumer loans | 115,376 |  |  | (8,515 | ) |  | 210 |  |  | (2,839 | ) |  | 140,731 |  |  | (125,864 | ) |  | — |  |  | — |  |  | 119,099 |
Corporate debt | 27,028 |  |  | (99 | ) |  | (1,687 | ) |  | 1,652 |  |  | 136,020 |  |  | (106,597 | ) |  | — |  |  | — |  |  | 56,317 |
Real estate owned | 12,522 |  |  | — |  |  | 2,291 |  |  | (545 | ) |  | 12,614 |  |  | (23,298 | ) |  | — |  |  | — |  |  | 3,584 |
Private corporate equity investments | 22,088 |  |  | — |  |  | 704 |  |  | (182 | ) |  | 11,617 |  |  | (18,709 | ) |  | — |  |  | — |  |  | 15,518 |
Total investments, at fair value | 486,974 |  |  | (12,918 | ) |  | 1,593 |  |  | (1,495 | ) |  | 411,425 |  |  | (412,667 | ) |  | 8,360 |  |  | (18,593 | ) |  | 462,679 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 6,332 |  |  | — |  |  | 1,068 |  |  | (476 | ) |  | 77 |  |  | (1,144 | ) |  | — |  |  | — |  |  | 5,857 |
Total return swaps | 85 |  |  | — |  |  | 3,119 |  |  | 111 |  |  | 1,377 |  |  | (4,496 | ) |  | — |  |  | — |  |  | 196 |
Warrants | 150 |  |  | — |  |  | (50 | ) |  | — |  |  | 7,486 |  |  | — |  |  | — |  |  | — |  |  | 7,586 |
Total financial derivatives– assets, at fair value | 6,567 |  |  | — |  |  | 4,137 |  |  | (365 | ) |  | 8,940 |  |  | (5,640 | ) |  | — |  |  | — |  |  | 13,639 |
Total investments and financial derivatives–assets, at fair value | $ | 493,541 |  |  | $ | (12,918 | ) |  | $ | 5,730 |  |  | $ | (1,860 | ) |  | $ | 420,365 |  |  | $ | (418,307 | ) |  | $ | 8,360 |  |  | $ | (18,593 | ) |  | $ | 476,318 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments sold short, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt | $ | (448 | ) |  | $ | (8 | ) |  | $ | 409 |  |  | $ | (566 | ) |  | $ | 32,230 |  |  | $ | (70,804 | ) |  | $ | — |  |  | $ | — |  |  | $ | (39,187 | )
Total investments sold short, at fair value | (448 | ) |  | (8 | ) |  | 409 |  |  | (566 | ) |  | 32,230 |  |  | (70,804 | ) |  | — |  |  | — |  |  | (39,187 | )
Financial derivatives– liabilities, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | (221 | ) |  | — |  |  | (61 | ) |  | (42 | ) |  | 47 |  |  | 15 |  |  | — |  |  | — |  |  | (262 | )
Total return swaps | (4,662 | ) |  | — |  |  | (6,508 | ) |  | 3,438 |  |  | 6,576 |  |  | (67 | ) |  | — |  |  | — |  |  | (1,223 | )
Total financial derivatives– liabilities, at fair value | (4,883 | ) |  | — |  |  | (6,569 | ) |  | 3,396 |  |  | 6,623 |  |  | (52 | ) |  | — |  |  | — |  |  | (1,485 | )
Guarantees: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Guarantees | (828 | ) |  | — |  |  | — |  |  | 678 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (150 | )
Total guarantees | (828 | ) |  | — |  |  | — |  |  | 678 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (150 | )
Total financial derivatives– liabilities and guarantees, at fair value | $ | (6,159 | ) |  | $ | (8 | ) |  | $ | (6,160 | ) |  | $ | 3,508 |  |  | $ | 38,853 |  |  | $ | (70,856 | ) |  | $ | — |  |  | $ | — |  |  | $ | (40,822 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the nine month period ended September 30, 2016. For Level 3 financial instruments held by the Company at September 30, 2016, change in net unrealized gain (loss) of $(10.4) million, $(0.3) million, $(0.3) million, $(1.2) million, and $0.7 million, for the nine month period ended September 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively. As of September 30, 2016, the Company transferred $18.6 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. In addition, as of September 30, 2016, the Company transferred $8.4 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. There were no transfers of financial instruments between Level 1 and Level 2 during the three or nine month periods ended September 30, 2017 and 2016.

X
- Definition Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2C -URI http://asc.fasb.org/extlink&oid=66048111&loc=SL7498348-110258 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quantitative information about the inputs used in the fair value measurement of assets. This disclosure may include, but is not limited to, the fair value of the asset, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsAssetsQuantitativeInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration